Newsmeme!
Discover News you didn't know existed
Research and Markets (http://www.researchandmarkets.com/research/ec987f/special_report_ke) has announced the addition of Decision Resources, Inc.'s new report "SPECIAL REPORT: Key Pricing and Reimbursement Trends for CNS Drugs" to their offering.
DUBLIN, Ireland----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "SPECIAL REPORT: Key Pricing and Reimbursement Trends for CNS Drugs" to their offering.
Comparison of the genomes of James Watson and Craig Venter shows how minor genetic differences make them respond to drugs differently
Andrew Feldmár: New research into the benefits of hallucinogens alongside psychotherapy is welcome: in my experience they change lives
Yesterday we picked up on Seattle mental health blogger Philip Dawdy's post about the FDA boldly going where no medical body has gone before: approving two atypical antipsychotics for use in treating "pediatric bipolar disorder ." The only problem is this disorder's existence is still controversial, let alone its treatment with drugs recommended for schizophrenia. It's not the FDA's job to ...
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |